Coenzyme A and Acyl Carrier Protein


STRUCTURE, OCCURRENCE, BIOLOGY AND ANALYSIS



Before a fatty acid can be metabolized in tissues, for example by being esterified, oxidized or subjected to synthetic modification, it must usually be activated by conversion to a Coenzyme A ester or acyl-CoA, with the fatty acid group linked to the terminal thiol moiety. This is true for the most primitive organisms, such as Archaea, through to humans. A thiol ester is a highly energetic bond that permits a facile transfer of the acyl group to receptor molecules, whether it is the simplest fatty acid of all, acetic acid (i.e. as acetyl-CoA), or one of the long-chain fatty acids.

Structural formula of Coenzyme A

Coenzyme A (CoASH or CoA) itself is a complex and highly polar molecule, consisting of adenosine 3',5'-diphosphate linked to 4-phosphopantethenic acid (vitamin B5) and thence to β-mercaptoethylamine, which is directly involved in acyl transfer reactions. The adenosine 3’,5’-diphosphate moiety functions as a recognition site, increasing the affinity of CoA binding to enzymes.

Not only is CoA  associated intimately with most reactions of fatty acids, but it is also a key molecule in the catabolism of carbohydrates via the citric acid cycle in which acetyl-CoA is a major end-product. The genes encoding the enzymes for coenzyme A biosynthesis have been identified and the structures of many proteins in the pathway have been determined. Although there are substantial sequence differences between prokaryotes and eukaryotes, coenzyme A is assembled in five steps from pantothenic acid in essentially the same way in both groups. However, pantothenic acid per se can only be synthesised by microorganisms (including gut flora) and plants and must be acquired largely from the diet by animals. In animals, the process is believed to occur entirely in the cytosol of cells, and the first and rate-limiting step involves the enzyme pantothenate kinase, several isoforms of which are known.

Scottish thistleIt is interesting that the 4-phosphopantetheine moiety, linked via its phosphate group to the hydroxyl group of serine, is the active component in another important molecule in lipid metabolism, Acyl Carrier Protein (ACP). This is a small (8.8 kDa) but ubiquitous and highly conserved carrier of acyl groups during the synthesis of fatty acids. In yeast and mammals, it forms a separate region within a multifunctional fatty acid synthase complex, but in bacteria and plastids it remains as a small monomeric protein, though closely associated with the other elements of the fatty acid synthase (see our web page on saturated fatty acids). However, the final step in fatty acid synthesis in many types of organism is transfer of the fatty acyl group from ACP to CoA.

Intracellular free fatty acids arising from  synthesis de novo or from the diet must be activated by a fatty acyl-CoA synthetase (fatty acid:CoA ligase) before they can be utilized for the synthesis of triacylglycerols, wax esters, long-chain aldehydes and alcohols, and complex lipids, or for covalent modification of proteins by myristoylation or palmitoylation. In addition, the fatty acyl-CoA synthetases are central to many aspects of intermediary metabolism.

Acyl CoA synthetases activate fatty acids through a process that is energy–dependent and requires ATP and CoA. It is a two-stage process, requiring magnesium ions in the first step, which involves the formation of an acyl-AMP intermediate. ATP is consumed and AMP and pyrophosphate are produced.

Biosynthesis of coenzyme A esters

At least five families of acyl CoA synthetases are known in humans with specificities for fatty acids in different chain-length groups, i.e. short-chain (2-3 carbons), medium-chain (4-12 carbons), long-chain (12-22 carbons), so-called ‘bubble-gum’ (14-24 carbons) and very-long-chain (18-26 or more carbons) fatty acid substrates. They are distinguished by two highly conserved sequence elements, i.e. an ATP/AMP binding motif, which is common to enzymes that form an adenylated intermediate, and a fatty acid binding motif. Multiple isoforms of these enzymes are known to be present in animals and other life forms, and six have been identified in the yeast genome while there are at least 26 in the human genome, for example. They are generally believed to be membrane bound and each isoform appears to be located in at a unique subcellular location, where it may contribute acyl-CoA to different metabolic pools or where it can participate in the transport of fatty acyl moieties across membranes. For example, there is appreciable sequence homology between the very-long-chain acyl CoA synthetases and certain fatty acid transport proteins in animals, and the significance of this is under active investigation.

Many bacterial species, both Gram-negative and Gram-positive, synthesise acyl-CoA esters for lipid synthesis, and this enables them to make efficient use of exogenous fatty acids. However, other bacterial species do not make use of CoA in this way but instead utilize newly synthesised acyl groups linked via the thiol bond to the acyl carrier protein (ACP), i.e. in the form that they are produced by the type II fatty acid synthase. Some species, including Escherichia coli, use both acyl-CoA esters and acyl-ACPs for synthesis of phosphatidic acid de novo. Many other bacterial species activate fatty acids in a very different way, i.e. as the fatty acyl phosphates (see below).

Scottish thistleCoA esters are required for a number of processes in addition to esterification. During fasting or starvation, intracellular long-chain fatty acids mobilized from adipose tissue reserves are catabolized as fuel by the mitochondrial β-oxidation pathway, and they must be first be converted to the CoA esters prior to synthesis of carnitine derivatives for translocation into the mitochondrion. Medium-chain fatty acids can enter mitochondria without carnitine transport but they must be still activated before β-oxidation can occur.

Similarly, peroxisomes in animal cells have a distinct fatty acid β-oxidation system with a separate set of enzymes, including as many as three acyl-CoA oxidases. The acyl-CoA oxidase 1 catalyses the β-oxidation of straight-chain acyl-CoAs, while acyl-CoA oxidase 2 is involved in the oxidation of the side-chain of bile-acid precursors, and acyl-CoA oxidase 3 catalyses the oxidation of methyl branched-chain CoA esters.

Activation is needed also for α-oxidation in tissues. In addition, most other biological reactions of fatty acids including chain elongation and desaturation (plants are an exception) require their activation.

In addition to their role in lipid biosynthesis and catabolism, CoA esters have been shown to regulate the activities of a variety of enzymes, including that of acetyl-CoA carboxylase, an essential enzyme in fatty acid synthesis. Long-chain acyl-CoA esters also bind to certain hormone receptors and have a signalling function. Many of the effects observed for free fatty acids in nuclear signalling may also be attributable to acyl-CoA esters.

As they have both polar and hydrophobic molecular components, CoA esters of long-chain fatty acids have strong detergent-like physical properties and have the potential to be disruptive towards cells. The intracellular concentration of free acyl-CoA esters is tightly controlled by feedback inhibition of the acyl-CoA synthetase, and is buffered by specific acyl-CoA binding proteins in the cytoplasm, which in effect reduce the concentration by up to 104 fold. Mitochondrial acyl-CoA concentrations are 10 fold higher than in the cytoplasm. At high concentrations, acyl-CoA are non-specific inhibitors of innumerable enzyme systems, and they must be removed from cells in part as their acyl-carnitine derivatives.

Catabolism: There is a family of acyl-CoA thioesterases, located in most cellular compartments, which catalyse the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A. Suggested functions for these enzymes include ligand supply for nuclear receptors, regulation and termination of fatty acid oxidation in mitochondria and peroxisomes, and control of the supply of acetate and of coenzyme A.

Pathological conditions, including certain hereditary conditions, that lead to impaired metabolism and accumulation of CoA and acyl-CoA within cells, trigger a sequence of reactions, which give rise to chronic illnesses.


Alternatives to CoA Esters – Fatty Acid Phosphates

Most bacteria, including such important human Gram-positive pathogens as Streptococcus pneumoniae and Staphylococcus aureus, are now known to lack the glycerophosphate acyl transferase enzymes that make use of CoA and ACP. Instead it has recently been discovered that they produce a fatty acyl phosphate as the reactive acyl donor.

Biosynthesis of acyl phosphates

The acyl phosphate is produced by reaction of acyl-ACP with phosphate catalysed by an acyl-ACP:phosphate acyltransferase, and the product then requires specific acyltransferases so that it can be utilized for the synthesis of phosphatidic acid. Although acyl phosphates are less stable than thio esters in vitro, this is obviously not a problem in vivo.


Analysis of Coenzyme A Esters

Because of their strongly amphipathic character, CoA esters are not the easiest compounds to analyse, and the reviews cited below should be consulted for a full discussion of the problems and methods. Extraction from tissues presents problems, and it may even be necessary to add a specific binding protein to ensure quantitative recoveries. Having obtained an appropriate extract, methods are available to separate short- and longer-chain fractions, and individual components can then be resolved by reversed-phase high-performance liquid chromatography. However, quantification can be a further problem, as it is not a straightforward matter to produce true solutions of pure compounds as standards. Electrospray-ionization tandem mass spectrometry now appears to hold particular promise for analysis.


Recommended Reading


W.W. Christie

Scottish Crop Research Institute (and MRS Lipid Analysis Unit), Invergowrie, Dundee (DD2 5DA), Scotland

Lipid Library